Guidance for Industry, Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations (U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2003)
[cited 2013 February]; Available from